Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pancreatic Diseases 1Gallbladder Diseases 1Choledocholithiasis 1Biliary Tract Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Has results × Duodenoscopes × Clear all
NCT05429203 2025-09-15

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

Stanford University

Phase NA Completed
319 enrolled 21 charts
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Diseases, Pancreatic Diseases, Pancreatic Neoplasms, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡